Atypical Presentation of Systemic Amyloid Light Chain (AL) Amyloidosis
James Faraci1,2, Joseph A Connor1, Sukhbir Randhawa1
1Department of Graduate Medical Education, Samaritan Medical Center, Watertown, USA.
Cureus
|July 14, 2025
Summary
Light chain amyloidosis (AL) is a plasma cell disorder causing organ damage. This case highlights an atypical presentation of AL amyloidosis in a 66-year-old female, emphasizing diagnostic challenges and the role of fat pad biopsy.
Area of Science:
- Cardiology
- Hematology
- Oncology
Background:
- Light chain (AL) amyloidosis originates from a plasma cell clone producing misfolded monoclonal light chains, leading to systemic organ damage.
- The systemic nature of AL amyloidosis often results in vague, nonspecific symptoms affecting multiple organ systems, complicating diagnosis.
- Atypical presentations, like isolated shortness of breath, can obscure the underlying diagnosis of AL amyloidosis.
Observation:
- A 66-year-old female presented with progressive shortness of breath, initially lacking other typical symptoms or significant past medical history.
- Imaging revealed bilateral pleural effusions, and ECG showed atrial fibrillation, both managed symptomatically.
- Transthoracic cardiac ultrasound suggested AL amyloidosis with a "grainy" myocardium, heart failure, and left ventricular hypertrophy, supported by serum and urine protein electrophoresis.
Findings:
- AL amyloidosis was confirmed via abdominal fat pad and bone marrow biopsies.
- Cardiac ultrasound proved valuable in preliminary diagnosis, but confirmatory testing remains essential.
- The fat pad biopsy was utilized as a readily available, technically simpler definitive diagnostic tool in this case.
Implications:
- This case underscores the importance of considering AL amyloidosis in patients with atypical or isolated symptoms, even without a prior history.
- The diagnostic utility of cardiac ultrasound and fat pad biopsy in AL amyloidosis is highlighted, alongside the need for established confirmatory methods.
- Timely diagnosis and transfer to specialized centers are crucial for accessing optimal treatment for AL amyloidosis, given the complexity of management and specialized medication requirements.
Related Concept Videos
Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K
Nephrotic Syndrome I : Introduction
31
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
31
Chronic Kidney Disease II: Clinical Manifestations
103
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
103
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
40
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
40
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
37
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
37
Myocarditis II: Clinical Features and Diagnostic Tests
25
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
25


